These results show that CLEC19A expression decreases in glioma tumors compared to normal brain tissues and its expression is significantly lower in aggressive glioma cell lines compared to1321N1 low-grade astrocytoma cell line. This evidence concerns the gene CLEC19A and central nervous system cancer.